PT Etana Biotechnologies Indonesia

PT Etana Biotechnologies Indonesia established since 2014, engaged in manufacturing, R&D and marketing of recombinant gene-technology, monoclonal antibody (MAB’s) drugs and vaccines. PT Etana Biotechnologies Indonesia has an international scale and advanced technology cooperating with known pharmaceutical companies to develop new products and markets. Vision: To become a biotech pharmaceutical company who provide better solution for better life through the features biology product with the best quality. Mission: To be an integrated biotech company in the business of manufacturing PIC/S standard and marketing of high quality and affordable biosimilars for Indonesia and other emerging countries.